AI assistant
Sending…
Instil Bio, Inc. — Director's Dealing 2021
Mar 23, 2021
33728_dirs_2021-03-22_d091263c-0c3e-4f80-8f43-6dc5ada79e4e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2021-03-18
Reporting Person: Binder Gwendolyn (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-18 | Stock Option (right to buy) | $20.00 | A | 52000 | Acquired | 2031-03-18 | Common Stock (52000) | Direct |
Footnotes
F1: The option will vest in 36 equal monthly installments commencing on April 18, 2021, subject to the Report Person's continued service as a director through the vesting date.
More from Instil Bio, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Annual Report
2026
Apr 24
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Mar 27
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2026
Jan 6
Interim / Quarterly Report
2025
Nov 13